A practical guide to contract due diligence and MSA diligence for M&A — how PE sponsors and corp dev teams test whether customer, supplier, and partner paper will still produce cash when ownership changes.
Deals underwrite logos and ignore the paper. Contract due diligence decides whether revenue is a portfolio of enforceable agreements or a pile of relationships that can walk at close. It is not the same as broad legal diligence (entity, cap table, litigation hygiene), pure commercial diligence (market demand and pricing power), or customer quality diligence (retention and cohort health). Contract diligence underwrites what the signed terms actually allow after control changes.
| Workstream | Primary question | Typical output |
|---|---|---|
| Contract DD | Do terms survive ownership change? | Abstraction, CoC/assignment map, kill clauses |
| Legal / corporate DD | Is the entity and liability stack clean? | Cap table, litigation, corporate formalities |
| Commercial DD | Is demand real and defensible? | Market, pricing, win rates, pipeline quality |
| Customer quality DD | Will customers stay and expand? | Cohorts, NPS, concentration, expansion |
| R&W / escrow | How is breach risk allocated? | Reps, baskets, escrow, RWI fit |
Map the contract stack: master services agreements, statements of work, order forms, purchase orders, channel and reseller agreements, strategic partnerships, and material vendor contracts. Measure what share of revenue and COGS sits under written terms vs handshake or expired paper. Flag multi-document hierarchies where the MSA says one thing and the latest SOW quietly rewrites price or liability. Connect coverage gaps to quality of earnings when booked revenue lacks durable paper.
For each material agreement, abstract change-of-control (CoC) triggers, consent requirements, notice periods, and whether a stock sale, asset sale, or merger is treated differently. Non-assignability without consent is a close risk and a financing risk. Government, healthcare, and large-enterprise paper often hard-codes anti-assignment. Link findings to legal diligence and deal structure (share vs asset) early enough to change the SPA path.
Score remaining term, auto-renewal mechanics, termination for convenience, termination for cause, and cure periods. A book of "recurring" revenue with 30-day TFC is not the same as multi-year committed ARR. Model the revenue at risk if the top accounts exit at first opportunity post-close. Align with customer diligence and SaaS metrics diligence when logos look sticky but paper is not.
Extract price floors, escalators, most-favored-customer (MFC) clauses, audit rights, volume commitments, and reopeners tied to benchmarks or public list prices. MFC and audit rights can destroy margin after a platform buy-and-build. Channel agreements with reverse chargebacks or marketing funds need the same treatment. Connect pricing fragility to commercial diligence and competitive diligence.
Abstract liability caps, carve-outs (IP infringement, data breach, fraud), indemnities, insurance requirements, SLAs with service credits, IP ownership of deliverables, and data-processing addenda. Uncapped breach liability or customer-owned IP on core product work can reprice the deal. Tie cyber and privacy clauses to cybersecurity diligence and data privacy diligence; tie IP ownership issues to IP diligence.
Turn the abstraction into an action list: which consents are conditions to close, which can be post-close with escrow, which contracts must be renegotiated before you underwrite the base case, and which vendors need dual-run or exit plans. PMI fails when Day-1 operations depend on a non-assignable critical vendor. See post-merger integration diligence and R&W diligence for how findings become SPA protection.
DI20-WELCOME) — useful for triage, not a full abstraction.
| Stage | Contract focus | Buyer action |
|---|---|---|
| Pre-LOI / IOI | Concentration, public majors, sector CoC norms | Price only theses that survive paper reality |
| LOI / exclusivity | Top-N MSA/SOW request list; vendor critical path | Data request; counsel abstraction scope |
| Confirmatory DD | CoC, assignment, TFC, MFC, liability, IP/data | Red/amber/green; consent & renegotiate plan |
| SPA / financing | Consents as conditions; reps on material contracts | R&W, escrow, RWI; financing conditions |
| Close / Day-1 | Executed consents; critical vendor dual-run | No orphaned revenue or ops dependency |
| Signal | Severity | Why it matters |
|---|---|---|
| Material revenue under CoC termination or hard consent | Deal-Killer | Book can vanish at close |
| Non-assignable critical vendor with no substitute | Deal-Killer | Operations fail Day-1 |
| Top customers on termination for convenience / short notice | Deal-Killer | Recurring revenue is optional |
| Broad MFC or audit rights across enterprise book | High | Margin compression after platform deals |
| Large share of revenue handshake / expired MSA | High | QoE and collectability risk |
| Uncapped liability or customer-owned core IP | High | Balance-sheet and product risk |
| Channel agreements with uncapped chargebacks | Watch | Revenue quality and cash timing |
| No consent tracker for SPA conditions | Watch | Close process stalls |
| Approach | Typical cost | Timeline | Best use |
|---|---|---|---|
| Full top-N contract abstraction + counsel | $15K–$80K+ | 2–5 weeks | Enterprise MSA books, regulated, CoC-heavy |
| Focused top-10 customers + critical vendors | $8K–$30K | 1–3 weeks | Mid-market PE with known concentration |
| Public first-pass risk pack | $49 | Minutes to hours | Triage before LOI / shortlist |
Before LOI, buyers use structured public research to pressure-test contract theses: customer concentration and disclosed major contracts, partner and government award signals, lawsuit themes about commercial disputes, sector norms for change-of-control and anti-assignment, and whether "recurring revenue" claims match industries known for short-notice termination paper. After LOI, the same hypotheses drive the data-room list — top MSAs, SOWs, critical vendors, side letters, and consent trackers — so counsel abstracts what can actually kill the thesis instead of sampling random files. The pack is screening research, not a substitute for full contract abstraction, counsel opinion, or negotiated consents.
⇧ Already delivered: Tesla (TSLA) · Alphabet (GOOGL) · Palantir (PLTR) — real orders, real SEC data, every claim source-cited.
Get a structured first-pass diligence pack on your target — useful input for contract / CoC / assignment / termination hypotheses, not a full contract abstraction.
Order report $39.20 → Free brief Sample PDF